187 related articles for article (PubMed ID: 17898541)
1. DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy.
Andrew AS; Karagas MR; Nelson HH; Guarrera S; Polidoro S; Gamberini S; Sacerdote C; Moore JH; Kelsey KT; Demidenko E; Vineis P; Matullo G
Hum Hered; 2008; 65(2):105-18. PubMed ID: 17898541
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study.
Matullo G; Guarrera S; Sacerdote C; Polidoro S; Davico L; Gamberini S; Karagas M; Casetta G; Rolle L; Piazza A; Vineis P
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2569-78. PubMed ID: 16284380
[TBL] [Abstract][Full Text] [Related]
4. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility.
Andrew AS; Nelson HH; Kelsey KT; Moore JH; Meng AC; Casella DP; Tosteson TD; Schned AR; Karagas MR
Carcinogenesis; 2006 May; 27(5):1030-7. PubMed ID: 16311243
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
[TBL] [Abstract][Full Text] [Related]
6. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk.
Ito H; Matsuo K; Hamajima N; Mitsudomi T; Sugiura T; Saito T; Yasue T; Lee KM; Kang D; Yoo KY; Sato S; Ueda R; Tajima K
Carcinogenesis; 2004 Aug; 25(8):1395-401. PubMed ID: 15044328
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand.
Kietthubthew S; Sriplung H; Au WW; Ishida T
Int J Hyg Environ Health; 2006 Jan; 209(1):21-9. PubMed ID: 16373199
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A
Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937
[TBL] [Abstract][Full Text] [Related]
9. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study.
Matullo G; Guarrera S; Carturan S; Peluso M; Malaveille C; Davico L; Piazza A; Vineis P
Int J Cancer; 2001 May; 92(4):562-7. PubMed ID: 11304692
[TBL] [Abstract][Full Text] [Related]
10. High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk.
Chen M; Kamat AM; Huang M; Grossman HB; Dinney CP; Lerner SP; Wu X; Gu J
Carcinogenesis; 2007 Oct; 28(10):2160-5. PubMed ID: 17728339
[TBL] [Abstract][Full Text] [Related]
11. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
Popanda O; Schattenberg T; Phong CT; Butkiewicz D; Risch A; Edler L; Kayser K; Dienemann H; Schulz V; Drings P; Bartsch H; Schmezer P
Carcinogenesis; 2004 Dec; 25(12):2433-41. PubMed ID: 15333465
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in DNA repair and metabolic genes in bladder cancer.
Sanyal S; Festa F; Sakano S; Zhang Z; Steineck G; Norming U; Wijkström H; Larsson P; Kumar R; Hemminki K
Carcinogenesis; 2004 May; 25(5):729-34. PubMed ID: 14688016
[TBL] [Abstract][Full Text] [Related]
13. XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk.
Stern MC; Siegmund KD; Conti DV; Corral R; Haile RW
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2384-90. PubMed ID: 17164360
[TBL] [Abstract][Full Text] [Related]
14. A systematic gene-gene and gene-environment interaction analysis of DNA repair genes XRCC1, XRCC2, XRCC3, XRCC4, and oral cancer risk.
Yang CH; Lin YD; Yen CY; Chuang LY; Chang HW
OMICS; 2015 Apr; 19(4):238-47. PubMed ID: 25831063
[TBL] [Abstract][Full Text] [Related]
15. DNA-repair genetic polymorphisms and breast cancer risk.
Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
[TBL] [Abstract][Full Text] [Related]
17. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.
Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland L; Phillips DH; Canzian F; Haugen A
Carcinogenesis; 2006 Mar; 27(3):560-7. PubMed ID: 16195237
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer.
Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ
Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide excision repair gene polymorphisms may predict acute toxicity in patients treated with chemoradiotherapy for bladder cancer.
Sakano S; Hinoda Y; Sasaki M; Wada T; Matsumoto H; Eguchi S; Shinohara A; Kawai Y; Hara T; Nagao K; Hara T; Naito K; Matsuyama H
Pharmacogenomics; 2010 Oct; 11(10):1377-87. PubMed ID: 21047201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
